Satsuma Pharmaceuticals - Delisted Stock
Satsuma Pharmaceuticals is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Satsuma Pharmaceuticals was actively traded.
Valuation
Check how we calculate scores
Satsuma Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Satsuma Pharmaceuticals market risk premium is the additional return an investor will receive from holding Satsuma Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Satsuma Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Satsuma Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Satsuma Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.39 | |||
| Semi Deviation | 3.54 | |||
| Standard Deviation | 8.57 | |||
| Variance | 73.46 |
View Satsuma Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Satsuma Pharmaceuticals Corporate Management
Elected by the shareholders, the Satsuma Pharmaceuticals' board of directors comprises two types of representatives: Satsuma Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Satsuma. The board's role is to monitor Satsuma Pharmaceuticals' management team and ensure that shareholders' interests are well served. Satsuma Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Satsuma Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Schultz | Manufacturing Chemistry | Profile | |
| Robert Janosky | Chief Officer | Profile | |
| John MBA | CEO Pres | Profile | |
| Detlef Albrecht | Chief Officer | Profile | |
| Mic Iwashima | VP Operations | Profile | |
| Thomas ONeil | Chief Officer | Profile | |
| Shannon Strom | VP Affairs | Profile |
Still Interested in Satsuma Pharmaceuticals?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Satsuma Stock
If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |